Metabolism of methoxyphenamine and 2-methoxyamphetamine in P4502D6-transfected cells and cell preparations
- 1 January 1995
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 25 (9), 895-906
- https://doi.org/10.3109/00498259509046661
Abstract
1. Control and P4502D6-transfected human B-lymphoblastoid cell lines (cHol and h2D6v2 respectively) were used to study 2D6-mediated metabolism of methoxyphenamine (MPA) and 2-methoxyamphetamine (2MA). The main metabolites were products of O-dealkylation and aromatic hydroxylation at the 5-position. In addition, N-desmethyl-methoxyphenamine (NDMP) was also identified as a minor metabolite of MPA in extracts of these cells, confirming previous reports of 2D6-mediated N-demethylation of MPA. 2. An additional ring-hydroxylated metabolite of MPA and 2MA has been tentatively identified as the corresponding 3-hydroxy-2-methoxy derivative. 3. MPA metabolism in whole cells was time dependent, with approximately 30% of the MPA metabolized after 72h. A 35% conversion of MPA was achieved on average with cell lysates. Only 18% 2MA was metabolized. By contrast, control cells (cHol) showed no evidence of any MPA or 2MA metabolites even after 96-h incubation. 4. Continuous presence of haemin/dimethylsulphoxide (DMSO) throughout the 4-day incubation with MPA resulted in a shift in the metabolite profile towards the production of NDMP at the expense of the other products. 5. In summary, h2D6v2 cells, lysates and microsomes can form all metabolites of MPA and can be used in drug interaction studies.Keywords
This publication has 18 references indexed in Scilit:
- The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomes.British Journal of Clinical Pharmacology, 1994
- Characterization of a human cell line expressing high levels of cDNA-derived CYP2D6Pharmacogenetics, 1993
- Problems and opportunities in toxicity testing arising from species differences in xenobiotic metabolismToxicology Letters, 1992
- The genetic polymorphism of debrisoquine/sparteine metabolism — Clinical aspectsPharmacology & Therapeutics, 1990
- Effect of Sparteine and Quinidine on the Metabolism of Methoxyphenamine byCunninghamella BainieriXenobiotica, 1989
- Microbial metabolism of phenelzine and pheniprazineLife Sciences, 1988
- The identification of two new urinary metabolites of fenfluramine in manXenobiotica, 1983
- Identification of new secondary metabolites of methoxyphenamine in manXenobiotica, 1983
- Metabolism of (+/-)-N-(n-propyl) amphetamine by Cunninghamella echinulataApplied and Environmental Microbiology, 1979
- Excretion of methoxyphenamine and its metabolites in urineJournal of Chromatography A, 1976